Teriparatide increases BMD in patients with glucocorticoid-Induced osteoporosis
Teriparatide or Alendronate in Glucocorticoid-Induced OsteoporosisN Engl J Med. 2007 Nov 15;357(20):2028-39
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
428 patients with glucocorticoid-induced osteoporosis were randomised to receive one of two treatments. The first group received a treatment of 20 Î¼g teriparatide daily while the second group received a 10 mg alendronate treatment. The primary outcome was change in bone mineral density at the lumbar spine from baseline to the 18-month follow-up. Results indicated that bone mineral density increas...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE